Ulrike Hübenthal

1.2k total citations
13 papers, 770 citations indexed

About

Ulrike Hübenthal is a scholar working on Molecular Biology, Small Animals and Cancer Research. According to data from OpenAlex, Ulrike Hübenthal has authored 13 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Small Animals and 4 papers in Cancer Research. Recurrent topics in Ulrike Hübenthal's work include Carcinogens and Genotoxicity Assessment (4 papers), Animal testing and alternatives (4 papers) and Pluripotent Stem Cells Research (3 papers). Ulrike Hübenthal is often cited by papers focused on Carcinogens and Genotoxicity Assessment (4 papers), Animal testing and alternatives (4 papers) and Pluripotent Stem Cells Research (3 papers). Ulrike Hübenthal collaborates with scholars based in Germany, United Kingdom and United States. Ulrike Hübenthal's co-authors include Ellen Fritsche, Josef Abel, Jean Krutmann, Christine Götz, Hans F. Merk, Melanie Wurm, Christian Calles, Thorsten Bernsmann, Jason E. Cline and Agneta Rannug and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Environmental Health Perspectives and Chemosphere.

In The Last Decade

Ulrike Hübenthal

13 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrike Hübenthal Germany	8	261	211	186	117	94	13	770
Jason E. Cline Germany	5	181 0.7×	232 1.1×	135 0.7×	82 0.7×	95 1.0×	5	668
Roland Pfeiffer Germany	5	48 0.2×	557 2.6×	87 0.5×	103 0.9×	37 0.4×	8	1.2k
Jorge M. Naciff United States	23	383 1.5×	486 2.3×	19 0.1×	170 1.5×	103 1.1×	35	1.2k
Nobuya Imatanaka Japan	15	338 1.3×	113 0.5×	20 0.1×	79 0.7×	28 0.3×	33	740
Wojciech Krzeptowski Poland	17	170 0.7×	211 1.0×	47 0.3×	47 0.4×	29 0.3×	34	714
Kayo Sumida Japan	20	137 0.5×	422 2.0×	7 0.0×	274 2.3×	28 0.3×	50	891
William H. Hanneman United States	20	302 1.2×	265 1.3×	5 0.0×	144 1.2×	82 0.9×	44	967
Noriko Kawamura Japan	16	44 0.2×	275 1.3×	23 0.1×	65 0.6×	54 0.6×	45	679
Seong Soon Kim South Korea	13	120 0.5×	132 0.6×	15 0.1×	18 0.2×	25 0.3×	49	578
Erica Buoso Italy	19	199 0.8×	356 1.7×	5 0.0×	92 0.8×	180 1.9×	31	974

Countries citing papers authored by Ulrike Hübenthal

Since Specialization

Citations

This map shows the geographic impact of Ulrike Hübenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Hübenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Hübenthal more than expected).

Fields of papers citing papers by Ulrike Hübenthal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Hübenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Hübenthal. The network helps show where Ulrike Hübenthal may publish in the future.

Co-authorship network of co-authors of Ulrike Hübenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Hübenthal. A scholar is included among the top collaborators of Ulrike Hübenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Hübenthal. Ulrike Hübenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Klose, Jördis, Farina Bendt, Ulrike Hübenthal, et al.. (2022). Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro. Cell Biology and Toxicology. 39(1). 319–343. 5 indexed citations

Nickel, Ann‐Christin, Daniel Picard, Andrea Rossi, et al.. (2022). Progenitor cells derived from gene‐engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology. Biotechnology Journal. 17(6). e2100693–e2100693. 1 indexed citations

Hartmann, Julia, Julia Tigges, Stefan Masjosthusmann, et al.. (2020). Characterization and application of electrically active neuronal networks established from human induced pluripotent stem cell-derived neural progenitor cells for neurotoxicity evaluation. Stem Cell Research. 45. 101761–101761. 23 indexed citations

Masjosthusmann, Stefan, Jonathan Blum, Kristina Bartmann, et al.. (2020). Establishment of an a priori protocol for the implementation and interpretation of an in‐vitro testing battery for the assessment of developmental neurotoxicity. EFSA Supporting Publications. 17(10). 64 indexed citations

Masjosthusmann, Stefan, et al.. (2019). Arsenite interrupts neurodevelopmental processes of human and rat neural progenitor cells: The role of reactive oxygen species and species-specific antioxidative defense. Chemosphere. 235. 447–456. 24 indexed citations

Masjosthusmann, Stefan, Jördis Klose, René Deenen, et al.. (2018). A transcriptome comparison of time-matched developing human, mouse and rat neural progenitor cells reveals human uniqueness. Toxicology and Applied Pharmacology. 354. 40–55. 22 indexed citations

Fritsche, Ellen, Stefan Masjosthusmann, Jenny Baumann, et al.. (2018). Neurospheres for species-specific, medium-throughput analyses of developmental neurotoxicity (DNT) Evaluation. Toxicology Letters. 295. S122–S123. 1 indexed citations

Götz, Christine, Roland Pfeiffer, Julia Tigges, et al.. (2012). Xenobiotic metabolism capacities of human skin in comparison with a 3D‐epidermis model and keratinocyte‐based cell culture asin vitroalternatives for chemical testing: phase II enzymes. Experimental Dermatology. 21(5). 364–369. 107 indexed citations

Götz, Christine, Nicola J. Hewitt, E. Jermann, et al.. (2011). Effects of the genotoxic compounds, benzo[a]pyrene and cyclophosphamide on phase 1 and 2 activities in EpiDerm™ models. Xenobiotica. 42(6). 526–537. 11 indexed citations

10.

Götz, Claudia, Roland Pfeiffer, Ulrike Hübenthal, et al.. (2010). The COLIPA skin metabolism project: Do in vitro alternatives comprise adequate detoxification capacities for chemical testing in skin?. Toxicology Letters. 196. S145–S145. 2 indexed citations

11.

Schreiber, Timm, Kathrin Gaßmann, Christine Götz, et al.. (2009). Polybrominated Diphenyl Ethers Induce Developmental Neurotoxicity in a Human in Vitro Model: Evidence for Endocrine Disruption. Environmental Health Perspectives. 118(4). 572–578. 163 indexed citations

12.

Götz, Christine, Roland Pfeiffer, Ulrike Hübenthal, et al.. (2009). Metabolic capacities of in vitro alternatives for chemical testing in skin: Insights from the Colipa skin metabolism project. Toxicology Letters. 189. S70–S70. 2 indexed citations

13.

Fritsche, Ellen, Claudia Schäfer, Christian Calles, et al.. (2007). Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proceedings of the National Academy of Sciences. 104(21). 8851–8856. 345 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact